Poseida Therapeutics (PSTX)
NASDAQ:PSTX
Holding PSTX?
Track your performance easily

Poseida Therapeutics (PSTX) Financial Statements

469 Followers

Poseida Therapeutics Financial Overview

Poseida Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.187; its P/E ratio is -2.03; Poseida Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 25.97M$ 28.14M$ 25.00M$ 9.35M$ 20.01M
Gross Profit$ 25.97M$ 28.14M$ 25.00M$ 9.35M$ 20.01M
EBIT$ -29.11M$ -22.02M$ -23.08M$ -29.43M$ -25.32M
EBITDA$ -26.18M$ -20.64M$ -21.64M-$ -25.83M
Net Income Common Stockholders$ -31.37M$ -24.27M$ -25.35M$ -31.78M$ -27.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 237.81M$ 198.65M$ 212.20M$ 238.84M$ 214.61M
Total Assets$ 298.69M$ 262.58M$ 273.88M$ 302.25M$ 281.21M
Total Debt$ 83.65M$ 84.56M$ 85.42M$ 86.26M$ 87.08M
Net Debt$ -154.16M$ -114.08M$ -126.78M$ -152.58M$ -127.53M
Total Liabilities$ 237.87M$ 177.99M$ 170.18M$ 178.59M$ 145.91M
Stockholders Equity$ 60.85M$ 84.56M$ 103.70M$ 123.66M$ 135.26M
Cash Flow-
Free Cash Flow$ 37.38M$ -15.23M$ -29.05M-$ -34.50M
Operating Cash Flow$ 38.40M$ -15.10M$ -28.74M$ 7.90M$ -33.32M
Investing Cash Flow$ -61.20M$ 24.00M$ 47.71M$ -47.24M$ 43.07M
Financing Cash Flow-$ -43.00K-$ 14.94M-
Currency in USD

Poseida Therapeutics Earnings and Revenue History

Poseida Therapeutics Debt to Assets

Poseida Therapeutics Cash Flow

Poseida Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis